Teladoc Health, Inc. — 2023 Form 10-K Summary
Reporting period: Fiscal year ended December 31, 2023. This filing reports annual results; it does not provide a clear standalone Q4 income statement or cash flow summary.
Business context
Teladoc provides virtual medical care, chronic-condition management and mental health services through two reportable segments: Integrated Care, primarily business-to-business, and BetterHelp, primarily direct-to-consumer. The company completed approximately 18.4 million telehealth visits in 2023. Approximately 90 million U.S. members had access to at least one product or service; U.S. Integrated Care membership was 89.6 million.
Key financial metrics
| Metric | 2023 | 2022 |
|---|---|---|
| Revenue | $2.602 billion | $2.407 billion |
| Gross profit, calculated as revenue less cost of revenue | $1.842 billion; 70.8% margin | $1.663 billion; 69.1% margin |
| Operating loss | $248.6 million | $13.653 billion |
| Net loss | $220.4 million; $1.34 per diluted share | $13.660 billion; $84.60 per diluted share |
| Adjusted EBITDA, non-GAAP | $328.1 million; 12.6% of revenue | $246.5 million; 10.2% of revenue |
| Cash from operating activities | $350.0 million | $189.3 million |
| Free cash flow, non-GAAP | $193.7 million | $16.5 million |
| Cash and cash equivalents at year-end | $1.124 billion | $918.2 million |
| Convertible senior notes, net carrying value | $1.539 billion | $1.535 billion |
Current assets were $1.489 billion and current liabilities were $420.6 million at year-end 2023. The filing states the company was in compliance with debt covenants and expects existing cash to cover working capital, capital expenditures and contractual obligations for at least 12 months. No client represented more than 10% of consolidated revenue; the five largest Integrated Care customers accounted for 34% of that segment’s revenue.
Material changes versus 2022
- Revenue increased 8%, with access-fee revenue up 8%; access fees represented 88% of consolidated revenue. International revenue increased 19%, compared with 6% growth in the U.S.
- Integrated Care revenue rose 7% to $1.469 billion and segment Adjusted EBITDA rose 42% to $191.9 million; its Adjusted EBITDA margin increased to 13.1% from 9.8%.
- BetterHelp revenue increased 11% to $1.134 billion, while segment Adjusted EBITDA rose 19% to $136.2 million. BetterHelp revenue growth was supported by a 9% increase in average monthly paying users. Advertising and marketing expense increased 10% company-wide, substantially due to BetterHelp.
- Operating cash flow increased by $160.7 million. Free cash flow improved partly because capitalized software spending declined.
- The 2022 comparison includes $13.403 billion of goodwill impairment charges. No goodwill impairment was recorded in 2023; the remaining $1.073 billion of goodwill relates to BetterHelp.
- Amortization expense increased 33% to $325.9 million, including $37.5 million of additional 2023 expense from accelerated amortization of the Livongo trademark following the brand transition plan.
Outlook, risks and unusual items
- Management expects positive operating cash flow to increase in 2024, but the filing provides no clear numerical 2024 revenue or earnings guidance. Management’s cash-sufficiency statement covers at least the next 12 months.
- Following an operational review, the company expects $12 million to $16 million of pre-tax restructuring charges in 2024, approximately $11 million of which was expected in Q1 2024.
- Key stated risks include continued losses and uncertainty about achieving profitability; competition and client or member attrition; BetterHelp customer acquisition and marketing costs; provider availability; healthcare regulation and professional-entity arrangements; privacy, cybersecurity and data-use claims; debt repayment and potential conversion dilution; and possible future impairment of goodwill or other assets.
- BetterHelp refunds were approximately $93.0 million in 2023, compared with $79.2 million in 2022. The FTC approved a $7.8 million settlement and consent order in 2023; related putative class actions in the U.S. and Canada remain pending. The company also disclosed a patent-infringement lawsuit and an appeal of the dismissal of a securities class action.
- Management said it did not expect the disclosed litigation matters to have a material adverse impact, while noting that outcomes and potential losses are difficult to estimate. The company disclosed prior cybersecurity incidents but said management had not determined that any experienced incident had caused, or was reasonably likely to cause, a material impact.
- Seasonality affects quarterly results: Integrated Care activity follows client benefit-year start dates and cold-and-flu patterns; BetterHelp has typically reduced marketing in Q4 and increased it early in the year.
Important facts for investors to verify
- Review quarterly filings for standalone Q4 trends, especially BetterHelp growth, marketing efficiency, refunds and segment margins.
- Track operating cash flow against capitalized software spending, and assess the sustainability of reported free cash flow.
- Check the terms, maturity and potential cash or share settlement of the 2025 and 2027 convertible notes, including dilution exposure.
- Monitor execution and actual costs of 2024 efficiency and restructuring initiatives, as well as management’s progress toward profitability.
- Follow BetterHelp-related litigation and compliance obligations, and evaluate potential effects on customer trust, marketing practices and business results.
- Assess the sensitivity of BetterHelp goodwill and intangible assets to changes in growth, margins, discount rates and the company’s share price.